Dehydration News and Research

Latest Dehydration News and Research

Tips for avoiding heat stroke

As a major heat wave sweeps over the country, the University of Alabama at Birmingham Hospital has already treated one patient for heat stroke and is gearing up for more.

13 Jul 2011

Can you drink too much water? Experts say yes

Drinking adequate amounts of water is said to prevent kidney damage, help lose weight and increase concentration. However experts now warn that drinking eight glasses of water a day is not good after all – and could be harmful. They say that scientific claims behind long-standing government guidelines are worse than ‘nonsense’. The NHS – along with leading doctors and nutritionists – advises the public to drink about 1.2 litres (or two-and-a-half pints) of water per day.

13 Jul 2011

Majority of tonsil surgery in children performed during summer vacation

Scheduling tonsils to be removed figures into many parents' itineraries for their childrens' summer vacation, right up there with summer camp stays and family reunions. An estimated 500,000 children have the procedure each year.

6 Jul 2011

Checklist to stay healthy and active in summer

The summer is a great season for getting in shape. Whether by playing a sport, doing an aerobic exercise routine, or just returning to that familiar running path -- this is the time for activity.

2 Jul 2011

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

Genentech, a member of the Roche Group, announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin in combination with paclitaxel chemotherapy for previously untreated HER2-negative metastatic breast cancer.

30 Jun 2011

New data from JANUMET clinical study on type 2 diabetes presented at ADA 2011

In a new post-hoc analysis based on the American Association of Clinical Endocrinologists (AACE/ACE) diabetes algorithm presented at the American Diabetes Association (ADA) 71st Annual Scientific Sessions, significantly more patients with type 2 diabetes treated with JANUMET-tablets achieved blood sugar goals after 18 weeks compared to metformin as initial therapy.

27 Jun 2011

Groups join forces to research new diarrheal therapies

The Center for World Health and Medicine, the University of Missouri-St. Louis Medicinal Chemistry Group, and the Institute for One World Health have joined forces "to develop safe and effective anti-diarrhea drugs …

24 Jun 2011

Summer safety tips to keep kids safe

Summer fun is in full swing, which coincides with an increase in bumps, bruises, scrapes and possibly worse. To keep kids safe, prevention and first-aid should be at the forefront of parents' minds this summer according to Dr. Karen Judy, Loyola University Health System pediatric safety expert and professor of pediatrics at Loyola University Chicago Stritch School of Medicine.

23 Jun 2011

TESARO secures $101M in Series B financing

TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $101 million in a Series B financing to advance and expand the Company's cancer product portfolio.

21 Jun 2011

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Genentech, a member of the Roche Group, announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.

20 Jun 2011

Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.

20 Jun 2011

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

Allos Therapeutics, Inc. today reported results from a retrospective analysis of data from the Company's pivotal PROPEL trial which suggested that treatment with single-agent FOLOTYN may result in increased response rates and progression-free survival relative to the immediate prior line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.

17 Jun 2011

Unprescribed methods to bring on labor may not be effective

More than half of the women in a recently published survey reported that near the end of their pregnancies, they took it upon themselves to try to induce labor, mostly by walking, having sex, eating spicy food or stimulating their nipples.

17 Jun 2011

Tips for pregnant women during summer

Hot, humid and pregnant. Many women would call that a recipe for misery. But UAB obstetrician Kim Hoover, M.D., says there are real medical conditions that pregnant women should guard against to stay safe and healthy as the temperature rises.

10 Jun 2011

Millennium reports results from two VELCADE based combination studies against multiple myeloma

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two studies of VELCADE (bortezomib) for Injection based combinations in patients with relapsed or refractory multiple myeloma (MM).

8 Jun 2011

Keeping kids safe and hydrated in hazardous heat

The national weather service is predicting heat indexes to be well above 100 degrees. Add kids playing outside and outdoor summer activities in full swing to the dangerous heat and you've got a hazardous combination.

8 Jun 2011

ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO 2011

Celgene International Sàrl today announced that results from two investigator initiated studies including ABRAXANE, and bevacizumab in unresectable melanoma were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL.

7 Jun 2011

Celgene announces ABRAXANE plus gemcitabine, bevacizumab phase II trial data on breast cancer

Celgene International Sàrl today announced that results from an investigator-initiated phase II study of ABRAXANE, gemcitabine and bevacizumab as first-line treatment in metastatic breast cancer were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL.

7 Jun 2011

Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO

Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.

6 Jun 2011

American College of Gastroenterology offers resources on foodborne illness, tips for food safety

For consumers in the United States concerned by the outbreak of E. coli in Europe, the American College of Gastroenterology offers background on foodborne illness, tips for food safety, and expert insight from its resources on digestive health on what to do in the case of foodborne illness.

4 Jun 2011

Dehydration News and Research

Latest Dehydration News and Research

Tips for avoiding heat stroke

Can you drink too much water? Experts say yes

Majority of tonsil surgery in children performed during summer vacation

Checklist to stay healthy and active in summer

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

New data from JANUMET clinical study on type 2 diabetes presented at ADA 2011

Groups join forces to research new diarrheal therapies

Summer safety tips to keep kids safe

TESARO secures $101M in Series B financing

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

Unprescribed methods to bring on labor may not be effective

Tips for pregnant women during summer

Millennium reports results from two VELCADE based combination studies against multiple myeloma

Keeping kids safe and hydrated in hazardous heat

ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO 2011

Celgene announces ABRAXANE plus gemcitabine, bevacizumab phase II trial data on breast cancer

Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO

American College of Gastroenterology offers resources on foodborne illness, tips for food safety

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dehydration News and Research

Latest Dehydration News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in